Vaccine GLP and cGMP Analysis

Intertek provides GLP and cGMP testing and characterisation support for vaccine manufacturers and researchers.

A growing number of vaccines today are based on well-defined materials, including vaccines based on purified protein antigens of natural origin or produced by rDNA technology, polysaccharides, semi-synthetic poly- or oligosaccharide-protein conjugates and novel nucleic acid constructs. These products can raise challenges for characterisation. Through the application of a comprehensive suite of methods currently in use for evaluating carbohydrate, lipopolysaccharide, lipid, protein, glycoprotein, and lipoprotein components of vaccines, Intertek can provide support for vaccine manufacturers and researchers through out the vaccine development process.

Vaccine Analysis services include:  

• Protein Analysis  
• Viral analysis and characterisation 
• Oligonucleotide Medicine Analysis
• Aggregation State Characterization 
• Stability Studies for Biopharmaceuticals 

Request more information to see how Intertek can help your organization with Vaccine GLP and cGMP Analysis.